|
Skadden, Arps, Slate, Meagher & Flom and Zhong Lun Law Firm have advised China’s Everest Medicines on its $451 million IPO in Hong Kong, with Kirkland & Ellis and Tian Yuan Law Firm advising the joint sponsors and underwriters.
|
Davis Polk & Wardwell, Zhong Lun Law Firm and have advised Chinese biopharmaceutical company Zai Lab’s on its $761 million secondary listing on the mainboard of the Hong Kong Stock Exchange, with Simpson Thacher & Bartlett and Commerce & Finance Law Offices advising the underwriters.
|
On Aug. 11, the Standing Committee of China’s National People’s Congress (NPC) passed a decision to implement pilot measures that will allow Hong Kong lawyers to practice in nine cities in the Greater Bay Area. Lawyers in Hong Kong and on the mainland say the measures provide more room for the professional development of Hong Kong lawyers, and facilitate the growth of legal services on the mainland.
|
Davis Polk & Wardwell and Jia Yuan Law Offices have advised Chinese clinical trial and research firm Hangzhou Tigermed Consulting on its $1.38 billion Hong Kong IPO, with Freshfields Bruckhaus Deringer and Zhong Lun Law Firm representing the sponsors.
|
Skadden, Arps, Slate, Meagher & Flom, Gibson, Dunn & Crutcher and Zhong Lun Law Firm have advised China internet heavyweight NetEase on its $2.7 billion secondary listing in Hong Kong, with Davis Polk & Wardwell and JunHe advising the joint underwriters.
|
Zhong Lun Law Firm and O’Melveny & Myers have advised Chinese drug development service provider Pharmaron on its $588 million Hong Kong initial public offering, with JunHe and Skadden, Arps, Slate, Meagher & Flom advising the joint sponsors.
|
Chinese law firm Zhong Lun has welcomed a four-lawyer banking team – led by partner Joe Tam – in Hong Kong from Mayer Brown JSM.
|
Zhong Lun Law Firm has recruited corporate specialist Alan Xu as a partner at its Hong Kong office from Simmons & Simmons.
|
Zhong Lun Law Firm has hired corporate finance specialist Victor Pang as a partner in the firm’s Hong Kong office.
|
Allen & Gledhill is the lead firm advising on the planned IPO of Singapore property group Ascendas, which is looking to spin-off its hotel assets via a property trust in a listing worth up to S$823 million ($648 million).